Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 72
13
Diseases
1,350
Unique genes
0.286
Avg. similarity score
Gastric cancer
Most-connected disease (10 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Gastric cancer
Endometrial cancer
Esophageal cancer
Biliary tract cancer
Non-hodgkins lymphoma
Hepatocellular carcinoma
Cervical cancer
Pancreatic cancer
friedreich ataxia
Endometrial neoplasms
Polycystic ovary syndrome
thrombotic disease
Cardiofacio-neurodevelopmental syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Gastric cancer | 10 | 10 | 218 |
| Endometrial cancer | 9 | 9 | 174 |
| Esophageal cancer | 9 | 9 | 157 |
| Biliary tract cancer | 8 | 8 | 118 |
| Non-hodgkins lymphoma | 8 | 8 | 135 |
| Hepatocellular carcinoma | 6 | 6 | 649 |
| Cervical cancer | 5 | 5 | 227 |
| Pancreatic cancer | 5 | 5 | 251 |
| friedreich ataxia | 5 | 5 | 1 |
| Endometrial neoplasms | 2 | 2 | 132 |
| Polycystic ovary syndrome | 2 | 2 | 227 |
| thrombotic disease | 2 | 2 | 1 |
| Cardiofacio-neurodevelopmental syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases ‐ top 100 shown, download for all)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ATXN2 | 9 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Endometrial neoplasms and 5 more |
| AZGP1 | 9 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 5 more |
| ESR1 | 9 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Endometrial neoplasms and 5 more |
| FGFR2 | 9 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Endometrial neoplasms and 5 more |
| FXN | 9 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 5 more |
| HNF1B | 9 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Endometrial neoplasms and 5 more |
| SH2B3 | 9 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Endometrial neoplasms and 5 more |
| TOX3 | 9 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 5 more |
| ANKRD11 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| ARHGEF10L | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| ASIP | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| BABAM1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| BAD | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| BCL2L11 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| BNC2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| BPIFA3 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| BRCA2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| C11ORF65 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| CASP8 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| CCDC170 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| CDK5RAP1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| CELF2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| CERS2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| CHMP4B | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| CLK1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| DCAF4 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| DLGAP4 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| DPEP1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| EPB41L1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| EPHB6 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| FAM76B | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| FAM83C | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| FANCA | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| FARP1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| FBRSL1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| FIGLA | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| FOXP1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| FRY | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| GOLPH3L | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| GPR137 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| GRHPR | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| GRM5 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| HLA-B | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| HLA-DQB1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| HLA-DRA | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| HOXB13 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| IGF2BP2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| IRF4 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| JRK | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| KCNH1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| KCNQ1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| KIF20B | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| KRT5 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| LCTL | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| LDLRAD4 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| LRRIQ4 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| LY6K | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| MAP3K1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| MCL1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| MECOM | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| MLC1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| MMP9 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| MRTFA | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| MTAP | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| MTX1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| MYO9B | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| NCOA6 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| NHLRC1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| OCA2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| OR6C6 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| PADI6 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| PALB2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| PHF20 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| PIGU | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| POU2AF3 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| POU5F1B | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| PRMT6 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| PSCA | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| RAD51B | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| RALY | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| RBM25 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| RCC2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| RCCD1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| RGS22 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| RHOU | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| RNF19A | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| SEPTIN4 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| SLC45A2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| SLK | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| SMAD7 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| SMC2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| STMN3 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| STN1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| TAB2 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| TERT | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| TESPA1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| TEX29 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| TGM3 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| TMX1 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
| TP53 | 8 / 13 | Biliary tract cancer, Cervical cancer, Endometrial cancer, Esophageal cancer and 4 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Pathways in cancer | KEGG | 119 / 533 | 2.0× | 5.22e-14 | 1.39e-11 ✓ sig. |
| Human T-cell leukemia virus 1 infection | KEGG | 63 / 224 | 2.5× | 2.16e-12 | 4.45e-10 ✓ sig. |
| Gastric cancer | KEGG | 47 / 150 | 2.8× | 2.36e-11 | 3.89e-9 ✓ sig. |
| Prostate cancer | KEGG | 36 / 98 | 3.3× | 3.27e-11 | 5.26e-9 ✓ sig. |
| Colorectal cancer | KEGG | 33 / 87 | 3.4× | 7.97e-11 | 1.18e-8 ✓ sig. |
| EGFR tyrosine kinase inhibitor resistance | KEGG | 31 / 80 | 3.4× | 1.58e-10 | 2.19e-8 ✓ sig. |
| Cell cycle | KEGG | 46 / 158 | 2.6× | 5.99e-10 | 7.07e-8 ✓ sig. |
| Endocrine resistance | KEGG | 34 / 99 | 3.1× | 9.24e-10 | 1.04e-7 ✓ sig. |
| Melanoma | KEGG | 28 / 73 | 3.4× | 1.60e-9 | 1.69e-7 ✓ sig. |
| Breast cancer | KEGG | 43 / 148 | 2.6× | 2.33e-9 | 2.36e-7 ✓ sig. |
| PIP3 activates AKT signaling | Reactome | 31 / 93 | 3.0× | 1.15e-8 | 9.82e-7 ✓ sig. |
| Constitutive Signaling by Aberrant PI3K in Cancer | Reactome | 27 / 75 | 3.2× | 1.56e-8 | 1.29e-6 ✓ sig. |
| Bladder cancer | KEGG | 19 / 41 | 4.1× | 1.75e-8 | 1.42e-6 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 45 / 170 | 2.4× | 2.39e-8 | 1.89e-6 ✓ sig. |
| Pancreatic cancer | KEGG | 27 / 77 | 3.1× | 2.98e-8 | 2.28e-6 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cell division | GO:0051301 | 86 / 406 | 2.9× | 5.51e-20 | 8.97e-17 ✓ sig. |
| cell population proliferation | GO:0008283 | 66 / 263 | 3.5× | 1.24e-19 | 1.89e-16 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 174 / 1,208 | 2.0× | 2.41e-19 | 3.56e-16 ✓ sig. |
| positive regulation of cell population proliferation | GO:0008284 | 99 / 532 | 2.6× | 1.27e-18 | 1.67e-15 ✓ sig. |
| positive regulation of MAPK cascade | GO:0043410 | 54 / 224 | 3.3× | 1.71e-15 | 1.28e-12 ✓ sig. |
| male gonad development | GO:0008584 | 37 / 117 | 4.4× | 5.17e-15 | 3.54e-12 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 117 / 778 | 2.1× | 1.50e-14 | 9.44e-12 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 85 / 504 | 2.3× | 1.34e-13 | 7.22e-11 ✓ sig. |
| positive regulation of miRNA transcription | GO:1902895 | 23 / 56 | 5.7× | 1.47e-12 | 6.50e-10 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 47 / 217 | 3.0× | 7.24e-12 | 2.74e-9 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 131 / 1,002 | 1.8× | 1.35e-11 | 4.83e-9 ✓ sig. |
| negative regulation of apoptotic process | GO:0043066 | 82 / 524 | 2.2× | 2.03e-11 | 6.94e-9 ✓ sig. |
| mitotic spindle assembly checkpoint signaling | GO:0007094 | 16 / 30 | 7.4× | 2.78e-11 | 9.11e-9 ✓ sig. |
| stem cell proliferation | GO:0072089 | 20 / 54 | 5.1× | 3.90e-10 | 9.60e-8 ✓ sig. |
| negative regulation of cell population proliferation | GO:0008285 | 70 / 444 | 2.2× | 4.45e-10 | 1.08e-7 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Biliary tract cancer | Non-hodgkins lymphoma | 0.740 | 108 | 1.96e-236 | 1.23e-233 ✓ sig. |
| Biliary tract cancer | Esophageal cancer | 0.643 | 108 | 1.50e-223 | 8.50e-221 ✓ sig. |
| Esophageal cancer | Gastric cancer | 0.504 | 126 | 7.61e-221 | 3.81e-218 ✓ sig. |
| Biliary tract cancer | Endometrial cancer | 0.584 | 108 | 9.11e-216 | 4.46e-213 ✓ sig. |
| Esophageal cancer | Non-hodgkins lymphoma | 0.584 | 108 | 2.73e-209 | 1.23e-206 ✓ sig. |
| Endometrial cancer | Non-hodgkins lymphoma | 0.542 | 109 | 1.74e-204 | 6.98e-202 ✓ sig. |
| Biliary tract cancer | Cervical cancer | 0.460 | 109 | 6.22e-201 | 2.40e-198 ✓ sig. |
| Biliary tract cancer | Gastric cancer | 0.472 | 108 | 2.24e-200 | 8.50e-198 ✓ sig. |
| Cervical cancer | Non-hodgkins lymphoma | 0.440 | 111 | 9.03e-192 | 3.02e-189 ✓ sig. |
| Biliary tract cancer | Pancreatic cancer | 0.412 | 108 | 1.54e-191 | 5.08e-189 ✓ sig. |
| Gastric cancer | Non-hodgkins lymphoma | 0.445 | 109 | 6.82e-189 | 2.21e-186 ✓ sig. |
| Endometrial cancer | Esophageal cancer | 0.482 | 108 | 1.15e-188 | 3.68e-186 ✓ sig. |
| Non-hodgkins lymphoma | Pancreatic cancer | 0.387 | 108 | 2.52e-177 | 6.70e-175 ✓ sig. |
| Cervical cancer | Esophageal cancer | 0.395 | 109 | 3.37e-173 | 8.54e-171 ✓ sig. |
| Endometrial cancer | Gastric cancer | 0.389 | 110 | 2.57e-170 | 6.37e-168 ✓ sig. |
| Esophageal cancer | Pancreatic cancer | 0.368 | 110 | 2.80e-169 | 6.86e-167 ✓ sig. |
| Cervical cancer | Endometrial cancer | 0.372 | 109 | 2.44e-165 | 5.72e-163 ✓ sig. |
| Endometrial cancer | Pancreatic cancer | 0.348 | 110 | 2.67e-161 | 5.89e-159 ✓ sig. |
| Cervical cancer | Gastric cancer | 0.327 | 110 | 5.68e-152 | 1.13e-149 ✓ sig. |
| Gastric cancer | Pancreatic cancer | 0.317 | 113 | 8.85e-152 | 1.74e-149 ✓ sig. |
| Biliary tract cancer | Hepatocellular carcinoma | 0.169 | 111 | 6.28e-147 | 1.18e-144 ✓ sig. |
| Hepatocellular carcinoma | Non-hodgkins lymphoma | 0.163 | 110 | 1.94e-129 | 3.17e-127 ✓ sig. |
| Esophageal cancer | Hepatocellular carcinoma | 0.156 | 109 | 1.45e-114 | 2.13e-112 ✓ sig. |
| Endometrial cancer | Hepatocellular carcinoma | 0.156 | 111 | 2.99e-110 | 4.22e-108 ✓ sig. |
| Gastric cancer | Hepatocellular carcinoma | 0.153 | 115 | 9.93e-101 | 1.18e-98 ✓ sig. |
| Endometrial cancer | Endometrial neoplasms | 0.195 | 50 | 7.87e-65 | 5.54e-63 ✓ sig. |
| Hepatocellular carcinoma | Polycystic ovary syndrome | 0.031 | 26 | 3.67e-6 | 2.07e-5 ✓ sig. |
| Endometrial neoplasms | Polycystic ovary syndrome | 0.032 | 11 | 4.06e-6 | 2.26e-5 ✓ sig. |
| Biliary tract cancer | friedreich ataxia | 0.008 | 1 | 7.66e-3 | 8.96e-3 ✓ sig. |
| friedreich ataxia | Non-hodgkins lymphoma | 0.007 | 1 | 8.77e-3 | 1.01e-2 ✓ sig. |
| Esophageal cancer | thrombotic disease | 0.006 | 1 | 1.02e-2 | 1.15e-2 ✓ sig. |
| Esophageal cancer | friedreich ataxia | 0.006 | 1 | 1.02e-2 | 1.15e-2 ✓ sig. |
| Endometrial cancer | friedreich ataxia | 0.006 | 1 | 1.13e-2 | 1.27e-2 ✓ sig. |
| friedreich ataxia | Gastric cancer | 0.005 | 1 | 1.42e-2 | 1.58e-2 ✓ sig. |
| Cardiofacio-neurodevelopmental syndrome | Gastric cancer | 0.005 | 1 | 1.42e-2 | 1.58e-2 ✓ sig. |
| Gastric cancer | thrombotic disease | 0.005 | 1 | 1.42e-2 | 1.58e-2 ✓ sig. |